Tricyclic antidepressant toxicity

Clinical Toxicology
J B Rose

Abstract

Tricyclic antidepressants are dibenzazepine derivatives with adrenergic, anticholinergic, and direct cardio-depressant activity. Double-blind clinical studies show TCAD to be efficacious for two-thirds of depressed patients. Cardiac toxicity is significant, especially on diseased myocardium. Serious arrhythmias and intracardiac blocks have been reported on therapeutic doses. Tricyclic antidepressant overdose is a serious condition which is becoming progressively more common. The agents' principal toxicities are to the nervous system and the heart. The syndrome can be divided into three stages of varying severity. The vast majority of cases are in the mild Stage I. Some patients reach Stage II with major CNS effects and increasing intracardiac block. Stage III, which encompassed less than 5% of poisonings, is a potentially fatal situation with respiratory arrest, convulsions, and ventricular arrhythmias. Prevention is extremely important in poisoning therapy. Supportive measures are all that is generally needed for mild poisoning. Moderate and severe overdoses will require respiratory support, anticonvulsants, physostigmine, and beta-blockers. Cardioversion and pacing may be necessary.

References

May 1, 1975·The American Journal of Psychiatry·T A Petti, M Campbell
Apr 10, 1975·JAMA : the Journal of the American Medical Association·S J KantorJ M Perel
May 1, 1974·Archives of General Psychiatry·J B Morris, A T Beck
Sep 1, 1958·The American Journal of Psychiatry·H AZIMA, R H VISPO

Citations

Jan 1, 1989·Psychological Medicine. Monograph Supplement·S J WarringtonM Lader
May 1, 1981·The Journal of Clinical Investigation·J PintoR S Rivlin
Feb 1, 1981·Clinical Toxicology·A Poklis, G E Gantner
Mar 1, 1979·Clinical Toxicology·R A de ZeeuwJ S Gimbrère
Jan 1, 1990·Journal of Toxicology. Clinical Toxicology·A PoklisJ J Saady
Jan 1, 1979·Clinical Toxicology·R Woodhead
Dec 1, 2015·Future Medicinal Chemistry·Horrick SharmaAloke Dutta
Sep 1, 1994·The American Journal of Emergency Medicine·J G SchwartzJ J Carnahan
Jan 1, 1991·Forensic Science International : Synergy·H Druid, P Holmgren
Jan 1, 1981·Acta Psychiatrica Scandinavica. Supplementum·C D Burgess
Jan 1, 1985·Annals of Emergency Medicine·M Callaham, D Kassel
Dec 1, 1980·Neuropharmacology·C D Burgess, P Turner
Jan 1, 1982·European Journal of Clinical Pharmacology·C D BurgessC F George
Jun 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·M W Carney
Mar 1, 1983·Acta Pharmacologica Et Toxicologica·P Zandberg, B Sangster
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·A PoklisC R Crooks

Related Concepts

Tricyclic Antidepressive Agents
ratio-Desipramine
Electrocardiographic Recorders
Heart Diseases
Retrospective Studies

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

© 2021 Meta ULC. All rights reserved